We want our AI technology to
not only perform in the highest level,
but also to serve for ‘the right’ purposes.
For us, this is ‘saving more lives.’
We aim to solve the most critical issues
in cancer care today:
reduce medical cost and prolong survival.
As a company, our philosophy is
to follow value over profit.
Our eyes are fixed in the fundamental
and inherent values,
while we simply take a portion
of the fruit we bear.
Lunit, a portmanteau of ‘Learning unit,’ is a medical AI software company
devoted to providing AI-powered total cancer care.
Our AI solutions help discover cancer and predict cancer treatment outcomes,
achieving timely and individually-tailored cancer treatment.
Lunit Core Values
*Lunit AI researchers,
Seonwook Park and Thijs Kooi.
We are not afraid to step apart from
the crowd and become different.
We value originality and try hard to uphold it.
The strongest drive for achievement
comes from within oneself.
We are passionate and self-driven.
Live to Learn
Growth excites us. It is in our DNA.
We are people who enjoy learning and
there is nothing we can’t learn.
Build with Evidence
Ideas can come from intuitions,
but the journey in making ideas into
reality is built with robust evidence.
Push for Craftsmanship
We pursue craftsmanship to achieve
perfection and maintain high credibility.
We create an impact and make changes.
Love One Another
We value and appreciate the people
we work with, and this is how we put ourselves in others' shoes and think for
ways to help them.
A First Generation
Medical AI Start-up
Watch and learn more about LunitLunit YouTube
Chief Executive Officer
Brandon studied medicine in Seoul National University College of Medicine and is a board certified physician in Family Medicine, trained at Seoul National University Hospital. Prior to medical school, he graduated from KAIST with a bachelor’s degree in Biological Sciences. He has also received master’s degrees in both Public Health (MPH) and Business Administration (MBA). Brandon has a deep passion for medical research with much experience in both basic and clinical research, having published 30+ articles in world-renowned journals like Hepatology and Annals of Oncology.